|
|
|
|
LEADER |
01998cas a22004932a 4500 |
001 |
ebs728969e |
003 |
EBZ |
006 |
m d |||||| |
007 |
cr|unu|||||||| |
008 |
960713c19969999maubr p 0 0eng |
022 |
|
|
|y 1359-4117
|
035 |
|
|
|a (EBZ)ebs728969e
|
040 |
|
|
|a DNLM
|b eng
|d EBZ
|
042 |
|
|
|a pcc
|
050 |
0 |
0 |
|a RC270.8
|b .J68
|
060 |
0 |
0 |
|a W1
|b JO644XG
|
130 |
0 |
|
|a Journal of experimental therapeutics & oncology (Online)
|
222 |
1 |
0 |
|a Journal of Experimental Therapeutics & Oncology
|
245 |
0 |
0 |
|a Journal of experimental therapeutics & oncology
|h [electronic resource].
|
246 |
3 |
|
|a Journal of experimental therapeutics and oncology
|
260 |
|
|
|a London ;
|a Philadelphia :
|b Rapid Science Publishers,
|c c1996-
|
310 |
|
|
|a Bimonthly
|
362 |
0 |
|
|a Vol. 1, no. 1 (Jan. 1996)-
|
500 |
|
|
|a Title from cover.
|
500 |
|
|
|a Published: Malden, MA : Blackwell Science, <2002->
|
550 |
|
|
|a Official journal of the Anticancer Therapeutics and Oncology Society.
|
650 |
|
0 |
|a Cancer
|x Treatment
|v Periodicals.
|
650 |
|
0 |
|a Therapeutics, Experimental
|v Periodicals.
|
650 |
|
2 |
|a Drugs, Investigational
|x therapeutic use
|v Periodicals.
|
650 |
|
2 |
|a Neoplasms
|x drug therapy
|v Periodicals.
|
650 |
|
2 |
|a Neoplasms
|x therapy
|v Periodicals.
|
650 |
0 |
7 |
|a Cytostatikum.
|2 swd
|
650 |
0 |
7 |
|a Pharmakologie.
|2 swd
|
650 |
0 |
7 |
|a Zeitschrift.
|2 swd
|
650 |
0 |
7 |
|a Krebs (Medizin)
|2 swd
|
650 |
0 |
7 |
|a Pharmakotherapie.
|2 swd
|
710 |
2 |
|
|a Anticancer Therapeutics and Oncology Society.
|
773 |
0 |
|
|t Academic Search Premier
|d EBSCO
|
776 |
1 |
|
|t Journal of experimental therapeutics and oncology (Online)
|x 1533-869X
|w (DLC) 2001214634
|w (OCoLC)45944707
|
776 |
1 |
|
|t Journal of experimental therapeutics & oncology
|x 1359-4117
|w (OCoLC)35074595
|w (DLC)sn 96039433
|
856 |
4 |
0 |
|3 Full text available: Jan 2003-.
|z Available in Academic Search Premier.
|u https://search.ebscohost.com/direct.asp?db=aph&jid=%22HYE%22&scope=site
|
999 |
|
|
|c 86268
|d 86268
|
942 |
|
|
|z EBS
|
942 |
|
|
|c REL
|